Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma

Clin Transl Oncol. 2006 Feb;8(2):133-5. doi: 10.1007/s12094-006-0171-0.

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome with characteristic features. The diagnosis of BOOP requires the presence of a combination of pathological, clinical, and radiological features. We report the case of a lung cancer patient with bronquiloalveolar carcinoma (BAC) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Bronchiolo-Alveolar / chemically induced
  • Adenocarcinoma, Bronchiolo-Alveolar / complications
  • Adenocarcinoma, Bronchiolo-Alveolar / diagnosis*
  • Adenocarcinoma, Bronchiolo-Alveolar / drug therapy
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cryptogenic Organizing Pneumonia / chemically induced
  • Cryptogenic Organizing Pneumonia / diagnosis*
  • Cryptogenic Organizing Pneumonia / diagnostic imaging
  • Cryptogenic Organizing Pneumonia / drug therapy
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Diagnosis, Differential
  • Disease Progression
  • Docetaxel
  • Gemcitabine
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / drug therapy
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Respiratory Insufficiency / etiology
  • Taxoids / administration & dosage
  • Tomography, X-Ray Computed

Substances

  • Anti-Inflammatory Agents
  • Taxoids
  • Deoxycytidine
  • Docetaxel
  • Methylprednisolone
  • Gemcitabine